XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer : An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)

enthalten in: Cancer Communications | 2022

von Zhu, X. | Huang, M. | Wang, Y. | +31

Cover Image, Volume 42, Issue 4

enthalten in: Cancer Communications | 2022

von Zhu, X. | Huang, M. | Wang, Y. | +31